ClinicalTrials.Veeva

Menu

Effect of Hypoxic Conditioning on Cerebrovascular Health in the Elderly (HYPOXAGE)

Grenoble Alpes University Hospital Center (CHU) logo

Grenoble Alpes University Hospital Center (CHU)

Status

Enrolling

Conditions

Aging
Cognitive Decline
Cerebral Hypoxia
Hypoxia
Healthy Aging
Exercise
Brain Diseases

Treatments

Procedure: Hypoxia and/or Exercise

Study type

Interventional

Funder types

Other

Identifiers

NCT05048680
38RC20.460

Details and patient eligibility

About

In line with the ever-growing aging of Western populations, the development of preventive strategies to slow down the effects of aging on cardiovascular health represents a major challenge in order to preserve functional capacities and a sufficient quality of life in the elderly. The alteration of vascular function (at the cerebral and systemic level) with aging is an important feature in the clinical picture including a decrease in physical and cognitive capacities. Although physical activity is recognized as an essential means of combating the effects of aging, optimizing its effects by defining the most effective strategies of practice remains a key objective. Offering alternative interventions to exercise training is also necessary for people who are unwilling or unable to engage in a physical activity program. In this context, hypoxic conditioning, alone or in conjunction with rehabilitative exercise training, is a new therapeutic modality with strong preclinical validity, in particular from a cardiovascular standpoint, and used in other pathologies to improve cardiovascular function and exercise performance and quality of life. Our aim is, therefore, to investigate the effect of hypoxic conditioning (alone or in conjunction with exercise training) on cerebrovascular health in the elderly.

Enrollment

64 estimated patients

Sex

All

Ages

60 to 80 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • 60 to 80 years of age;
  • Being physically inactive (less than 150 min/week of moderate to intense physical activity);
  • No chronic cardiovascular, respiratory, metabolic or neuromuscular disease counterindicating an exercise training or hypoxic conditioning program;
  • Health coverage;
  • Being able to provide written fully informed consent.

Exclusion criteria

  • Body-mass index >30 kg/m2;
  • Smoking (> cigarettes/day);
  • Alcohol use (> 10g/day);
  • Mental disorder or history of mental disorder;
  • Beta-blockade treatment;
  • Inability or refusal to provide informed consent;
  • No health coverage
  • People exceeding the annual ceiling of allowances received as a result of their participation in other clinical trials;
  • People deprived of freedom by judicial or administrative decision;
  • People subject to legal protection, who cannot be included in clinical trials.

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Quadruple Blind

64 participants in 4 patient groups, including a placebo group

Hypoxia - Rest
Experimental group
Description:
Sessions of intermittent hypoxia at rest; 3 sessions/week; 8 weeks. To be compared with the placebo (normoxia) group at rest.
Treatment:
Procedure: Hypoxia and/or Exercise
Normoxia - Rest
Placebo Comparator group
Description:
Sessions of normoxia at rest; 3 sessions/week; 8 weeks.
Treatment:
Procedure: Hypoxia and/or Exercise
Hypoxia - Exercise
Experimental group
Description:
Sessions of exercise training under hypoxia; 3 sessions/week; 8 weeks. To be compared with the placebo (exercise under normoxia) group.
Treatment:
Procedure: Hypoxia and/or Exercise
Normoxia - Exercise
Active Comparator group
Description:
Sessions of exercise training under hypoxia; 3 sessions/week; 8 weeks.
Treatment:
Procedure: Hypoxia and/or Exercise

Trial contacts and locations

1

Loading...

Central trial contact

Samuel Vergès, PhD; Stéphane Doutreleau, MD, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems